EMA — authorised 26 April 2010
- Application: EMEA/H/C/001034
- Marketing authorisation holder: Pierre Fabre Medicament
- Local brand name: Milnacipran Pierre Fabre Medicament
- Status: rejected
🇪🇺 responders in European Union
EMA authorised responders on 26 April 2010
Marketing authorisations
EMA — authorised 26 April 2010
- Application: EMEA/H/C/001122
- Marketing authorisation holder: Pierre Fabre Medicament
- Local brand name: Impulsor
- Status: rejected
Other Other approved in European Union
Frequently asked questions
Is responders approved in European Union?
Yes. EMA authorised it on 26 April 2010; EMA authorised it on 26 April 2010.
Who is the marketing authorisation holder for responders in European Union?
Pierre Fabre Medicament holds the EU marketing authorisation.